Paclitaxel
-
Identifiers
CAS number
33069-62-4Molecular formula
C47H51NO14SMILES
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
Safety labels
Corrosive
Irritant
Health -
Odor profile
Fragrance Odorless 61.64% Balsamic 24.39% Sweet 22.64% Milky 21.85% Cooling 21.67% Fruity 20.48% Grape 19.86% Savory 19.68% Bitter 18.81% Vanilla 17.95% Flavor Bitter 90.36% Odorless 33.08% Bland 29.95% Sweet-like 22.12% Very mild 20.63% Cedarleaf 19.4% Heather 18.88% Broom 18.83% Parsley 18.69% Nitrile 18.61% Odor impact est.
Medium -
Properties
XLogP3-AA
2.5pKa est.
1.79 (strong acid)Molecular weight
853.9 g/molVapor pressure est.
- hPa @ 20°C
- hPa @ 25°C
Evaporation rate
Ultra slowBoiling point est.
2309°CMelting point expt.
- 415 to 421 °F (NTP, 1992)
- 216-217 °C
- 213-216 °C (decomposition)
- 213 - 216 °C
Flash point
- 228.81 ˚C est.
Solubility expt.
- Insoluble
- Insoluble in water
- 5.56e-03 g/L
-
Synonyms
- paclitaxel
- TAXOL
- 33069-62-4
- Yewtaxan
- Taxol A
- Plaxicel
- Genaxol
- Genetaxyl
- Ebetaxel
- Capxol
- OncoGel
- Genexol
- Intaxel
- Mitotax
- Pacliex
- Paxene
- Onxol
- TaxAlbin
- Cyclopax
- Paxceed
- Onxal
- EmPAC
- Taxus Liberte
- Taxus stent
- Zisu
- Tocosol Paclitaxel
- (-)-Paclitaxel
- Padexol
- Taxus
- EndoTAG 1
- LEP-ETU
- NSC-125973
- Nanoxel
- Paclitaxol
- Sindaxel
- Coroflex Please
- Cypher select
- Taxus Express
- DHP-107
- MBT 0206
- P88XT4IS4D
- BMS-181339-01
- Infinnium
- DHP 107
- Abraxane I.V. Suspension
- BMS 181339-01
- NK 105
- NK-105
- NSC125973
- Paclitaxel (taxus canadensis)
- QW 8184
- QW-8184
- Liposome-entrapped paclitaxel easy-to-use
- DTXSID9023413
- IG 001
- 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
- DTXCID603413
- (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
- CHEBI:45863
- 7 epi Taxol
- ABRAXANE COMPONENT PACLITAXEL
- ABI-007 COMPONENT PACLITAXEL
- NAB-PACLITAXEL COMPONENT PACLITAXEL
- NSC 125973
- (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate
- [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
- Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaS)-
- paclitaxelum
- Bris Taxol
- Taxol, Bris
- ((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate
- (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-(((2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl)oxy)-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.0^(3,10).0^(4,7))heptadec-13-en-2-yl benzoate
- PACITAXEL
- RefChem:6096
- Taxol 100
- PACLITAXEL PACLITAXEL
- L01CD01
- PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND
- Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
- (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-(((2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl)oxy)-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl benzoate
- Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,1-2alpha,12aalpha,12balpha))-
- Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxy-, 4,10-diacetate 2-benzoate, 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
- Abraxane
- LipoPac
- Genexol-PM
- ABI-007
- MFCD00869953
- (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate
- HSDB 6839
- ABI 007
- DRG-0190
- MBT-0206
- Paclitaxel (Taxol)
- Paclitaxel, Taxus brevifolia
- CHEMBL428647
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- NCGC00164367-01
- C47H51NO14
- nab-paclitaxel
- M02242
- Cynviloq
- Xorane
- Taxol (Paclitaxel)
- (NAB)-Paclitaxel
- SMR000857385
- EndoTAG-1
- SR-01000075350
- UNII-P88XT4IS4D
- Anzatax
- Nanotaxel
- Paclical
- Pacligel
- Paxoral
- l diacetate
- Paclitaxel?
- CCRIS 8143
- Anzatax;
- Paclitaxel CRS
- Paclitaxel HCL
- Paclitaxel [USAN:USP:INN:BAN]
- Abraxane (TN)
- [diacetoxy-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-dihydroxy-tetramethyl-oxo-[?]yl] benzoate
- Paclitaxel; 5beta,20-Epoxy-1,7beta-dihydroxy-9-oxotax-11-ene-2alpha,4,10beta,13alpha-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate]; Taxol; Docetaxel Anhydrous Impurity F; Docetaxel Impurity F
- Taxol A;
- CAS-33069-62-4
- Paclitaxel (natural)
- BMS-181339
- 33069-62-4
-
Applications
Paclitaxel (CAS 33069-62-4) is used primarily in the pharmaceutical sector as an anticancer agent for chemotherapy; it is manufactured and formulated as an API or finished dosage form, including nanoparticle albumin-bound formulations (nab-paclitaxel); it is also employed as an analytical reference standard in quality control and research, and production and distribution of Paclitaxel are subject to strict regulatory controls and GMP practices.
gpt-5-nano
-
Solubility @25˚C
Solvent Solubility (g/L) ethanol 24.64 methanol 55.56 isopropanol 17.85 water 0.3 ethyl acetate 21.63 n-propanol 21.03 acetone 94.83 n-butanol 12.03 acetonitrile 18.07 DMF 365.77 toluene 6.12 isobutanol 10.34 1,4-dioxane 89.74 methyl acetate 39.27 THF 223.58 2-butanone 49.41 n-pentanol 10.82 sec-butanol 11.65 n-hexane 0.25 ethylene glycol 26.71 NMP 324.77 cyclohexane 0.47 DMSO 396.82 n-butyl acetate 8.45 n-octanol 5.08 chloroform 49.16 n-propyl acetate 12.87 acetic acid 166.53 dichloromethane 42.25 cyclohexanone 75.39 propylene glycol 30.01 isopropyl acetate 11.85 DMAc 328.76 2-ethoxyethanol 60.07 isopentanol 6.7 n-heptane 0.24 ethyl formate 26.18 1,2-dichloroethane 24.67 n-hexanol 5.69 2-methoxyethanol 118.83 isobutyl acetate 5.45 tetrachloromethane 4.88 n-pentyl acetate 9.45 transcutol 38.62 n-heptanol 5.47 ethylbenzene 2.4 MIBK 10.55 2-propoxyethanol 42.21 tert-butanol 11.56 MTBE 6.98 2-butoxyethanol 24.02 propionic acid 42.19 o-xylene 3.68 formic acid 85.49 diethyl ether 10.55 m-xylene 2.77 p-xylene 3.56 chlorobenzene 8.26 dimethyl carbonate 57.65 n-octane 0.15 formamide 100.22 cyclopentanone 160.18 2-pentanone 26.48 anisole 11.43 cyclopentyl methyl ether 24.51 gamma-butyrolactone 168.36 1-methoxy-2-propanol 69.48 pyridine 59.85 3-pentanone 21.24 furfural 104.36 n-dodecane 0.13 diethylene glycol 45.96 diisopropyl ether 1.67 tert-amyl alcohol 9.04 acetylacetone 59.14 n-hexadecane 0.16 acetophenone 18.69 methyl propionate 37.54 isopentyl acetate 5.68 trichloroethylene 65.14 n-nonanol 5.08 cyclohexanol 10.81 benzyl alcohol 18.87 2-ethylhexanol 2.55 isooctanol 3.5 dipropyl ether 5.47 1,2-dichlorobenzene 7.17 ethyl lactate 14.68 propylene carbonate 46.56 n-methylformamide 121.98 2-pentanol 5.38 n-pentane 0.27 1-propoxy-2-propanol 21.04 1-methoxy-2-propyl acetate 17.3 2-(2-methoxypropoxy) propanol 16.77 mesitylene 1.34 ε-caprolactone 58.28 p-cymene 1.14 epichlorohydrin 117.07 1,1,1-trichloroethane 15.77 2-aminoethanol 33.89 morpholine-4-carbaldehyde 240.26 sulfolane 266.34 2,2,4-trimethylpentane 0.14 2-methyltetrahydrofuran 43.31 n-hexyl acetate 9.66 isooctane 0.07 2-(2-butoxyethoxy)ethanol 23.44 sec-butyl acetate 5.91 tert-butyl acetate 10.06 decalin 0.24 glycerin 65.73 diglyme 47.93 acrylic acid 64.59 isopropyl myristate 2.99 n-butyric acid 32.91 acetyl acetate 23.57 di(2-ethylhexyl) phthalate 5.11 ethyl propionate 11.66 nitromethane 224.96 1,2-diethoxyethane 11.75 benzonitrile 12.31 trioctyl phosphate 3.9 1-bromopropane 7.35 gamma-valerolactone 265.46 n-decanol 3.26 triethyl phosphate 4.89 4-methyl-2-pentanol 2.66 propionitrile 13.63 vinylene carbonate 49.58 1,1,2-trichlorotrifluoroethane 125.59 DMS 14.72 cumene 1.35 2-octanol 3.21 2-hexanone 16.96 octyl acetate 5.46 limonene 1.73 1,2-dimethoxyethane 75.96 ethyl orthosilicate 4.11 tributyl phosphate 3.68 diacetone alcohol 24.33 N,N-dimethylaniline 8.74 acrylonitrile 27.95 aniline 14.63 1,3-propanediol 41.94 bromobenzene 6.62 dibromomethane 19.8 1,1,2,2-tetrachloroethane 49.09 2-methyl-cyclohexyl acetate 6.46 tetrabutyl urea 8.24 diisobutyl methanol 1.33 2-phenylethanol 11.03 styrene 3.34 dioctyl adipate 6.79 dimethyl sulfate 108.53 ethyl butyrate 7.17 methyl lactate 47.76 butyl lactate 11.66 diethyl carbonate 5.53 propanediol butyl ether 23.53 triethyl orthoformate 6.36 p-tert-butyltoluene 1.11 methyl 4-tert-butylbenzoate 13.1 morpholine 109.8 tert-butylamine 3.24 n-dodecanol 2.08 dimethoxymethane 125.29 ethylene carbonate 37.23 cyrene 45.73 2-ethoxyethyl acetate 18.34 2-ethylhexyl acetate 4.53 1,2,4-trichlorobenzene 12.36 4-methylpyridine 36.06 dibutyl ether 3.44 2,6-dimethyl-4-heptanol 1.33 DEF 47.69 dimethyl isosorbide 27.8 tetrachloroethylene 28.04 eugenol 15.06 triacetin 16.78 span 80 16.18 1,4-butanediol 21.11 1,1-dichloroethane 18.0 2-methyl-1-pentanol 6.08 methyl formate 105.77 2-methyl-1-butanol 7.33 n-decane 0.26 butyronitrile 9.94 3,7-dimethyl-1-octanol 2.61 1-chlorooctane 1.58 1-chlorotetradecane 0.56 n-nonane 0.21 undecane 0.18 tert-butylcyclohexane 0.16 cyclooctane 0.15 cyclopentanol 25.23 tetrahydropyran 37.25 tert-amyl methyl ether 6.27 2,5,8-trioxanonane 32.39 1-hexene 1.35 2-isopropoxyethanol 25.81 2,2,2-trifluoroethanol 58.42 methyl butyrate 17.48 Scent© AI
| Maximum acceptable concentrations in the finished product (%) | |||
|---|---|---|---|
|
Category 1
Products applied to the lips
|
No restriction |
Category 7A
Rinse-off products applied to the hair with some hand contact
|
No restriction |
|
Category 2
Products applied to the axillae
|
No restriction |
Category 7B
Leave-on products applied to the hair with some hand contact
|
No restriction |
|
Category 3
Products applied to the face/body using fingertips
|
No restriction |
Category 8
Products with significant anogenital exposure
|
No restriction |
|
Category 4
Products related to fine fragrance
|
No restriction |
Category 9
Products with body and hand exposure, primarily rinse off
|
No restriction |
|
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
|
No restriction |
Category 10A
Household care products with mostly hand contact
|
No restriction |
|
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
|
No restriction |
Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
|
No restriction |
|
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
|
No restriction |
Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
|
No restriction |
|
Category 5D
Baby Creams, baby Oils and baby talc
|
No restriction |
Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
|
No restriction |
|
Category 6
Products with oral and lip exposure
|
No restriction |
Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
|
No restriction |